← Back to Search
Cytoreductive Surgery And Hyperthermic Intrapleural Chemotherapy For Malignant Pleural Diseases: Preliminary Experience.
M. Migliore, D. Calvo, Alessandra Criscione, C. Viola, G. Privitera, C. Spatola, H. Parrà, S. Palmucci, N. Ciancio, R. Caltabiano, G. Di Maria
Published 2015 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Cytoreductive surgery and hyperthermic-intraoperative-intrapleural-chemotherapy (HITHOC) is a known approach for malignant pleural diseases (MPD). This study was started to clarify the role of cytoreductive surgery and HITHOC in MPD. Criteria of inclusion were early-stage disease in malignant pleural mesothelioma (MPM), young age, good condition and selected stage-M1a lung cancer. Six patients with MPM and two patients with lung cancer were enrolled. After surgical debulking, intrapleural cisplatin was administered for 60 min at 42.5°C. Wedge, rib resection and repaired diaphragm were added in three, one and one patient, respectively. Morbidity, toxicity and mortality was nil. Hospital stay was 8 days. Mean survival is 13.6 months. This experience confirms that cytoreductive surgery and HITHOC is a good option in the treatment of MPD. A randomized controlled trial is necessary.
This paper references
Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure.
O. Rena (2012)
Intrapleural hyperthermic perfusion with chemotherapy increases apoptosis in malignant pleuritis.
Y. Matsuzaki (2004)
Lung cancer and pleural mesothelioma
G. D. Maria (2014)
Malignant pleural mesothelioma: factors influencing the prognosis.
T. Mineo (2012)
Assessment of cisplatin concentration and depth of penetration in human lung tissue after hyperthermic exposure.
M. Ried (2015)
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.
W. Richards (2006)
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
V. Rusch (2001)
Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience.
M. Ried (2013)
Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial
R. Rintoul (2014)
Progress means change: reflections on two articles about pleural disease.
T. Welte (2013)
Cytoreductive Surgery Combined With Intraoperative Hyperthermic Intrathoracic Chemotherapy for Stage I Malignant Pleural Mesothelioma
S. van Ruth (2003)
Surgery in the treatment of malignant pleural mesothelioma: recruitment into trials should be the default position
A. Datta (2013)
Efficacy and safety of single-trocar technique for minimally invasive surgery of the chest in the treatment of noncomplex pleural disease.
M. Migliore (2003)
Effect of Cytoreductive Surgery Combined with Intraoperative Intra-Thoracic Hyperthermic Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
Myat Aung Kyaw (2014)
Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.
D. Sugarbaker (2013)
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
T. Treasure (2011)
Intrapleural hyperthermic perfusion chemotherapy in subjects with metastatic pleural malignancies.
A. Işık (2013)
Cytoreductive surgery and post-operative heated pleural chemotherapy for the management of pleural surface malignancy
K. Kodama (2013)
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma.
C. Cao (2014)
Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality.
B. Burt (2014)
Extrapleural pneumonectomy for malignant mesothelioma: an Italian multicenter retrospective study.
L. Spaggiari (2014)
Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.
T. R. Tilleman (2009)
Excision of the primary in stage IV non-small cell lung cancer (NSCLC): A feasibility study
A. Dawson (2015)
Intraoperative hyperthermic chemotherapy perfusion for malignant pleural mesothelioma: an in vitro evaluation.
R. Cameron (2013)
Limitation of Pencil Beam Convolution (PBC) Algorithm for Photon Dose Calculations in Inhomogeneous Medium
Tesering Dorje (2014)
External beam radiation therapy for the treatment of pleural mesothelioma.
E. Baldini (2004)
Surgical resection of mesothelioma: an evidence-free practice
Y. Lee (2014)
A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
V. Rusch (1994)
211 Excision of the primary in stage IV non-small cell lung cancer (NSCLC): A feasibility study
A. Dawson (2014)
Thoracoscopic surgery, video-thoracoscopic surgery, or VATS: a confusion in definition.
M. Migliore (2000)
Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.
E. de Bree (2002)
The treatment of pleural carcinosis with malignant pleural effusion.
M. Ried (2013)
This paper is referenced by
Intensity-modulated radiotherapy for relapsed malignant pleural mesothelioma.
C. Spatola (2016)
Intraoperative hypertherme intrathorakale Chemotherapie
T. Markowiak (2018)
Non-small cell lung cancer, pleural effusion and carcinomatosis: always a criterion of inoperability?
P. Yablonskii (2020)
Surgery for "advanced" lung and esophageal cancer: new horizons or false dawn?
M. Migliore (2018)
Does cytoreduction surgery and hyperthermic intrathoracic chemotherapy prolong survival in patients with N0–N1 nonsmall cell lung cancer and malignant pleural effusion?
M. Migliore (2019)
Hypertherme intrathorakale Chemotherapie in der Thoraxchirurgie
H. Hofmann (2019)
Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experience.
M. Migliore (2015)
Debulking surgery and hyperthermic intrathoracic chemotherapy (HITHOC) for lung cancer.
M. Migliore (2017)
Clinical outcomes of cytoreductive surgery combined with intrapleural perfusion of hyperthermic chemotherapy in advanced lung adenocarcinoma with pleural dissemination.
Eunjue Yi (2016)
Protocol of a retrospective, multicentre observational study on hyperthermic intrathoracic chemotherapy in Germany
T. Markowiak (2020)
Induction or adjuvant chemotherapy for radical multimodality therapy
Annabel J Sharkey (2018)
Management of recurrence after initial surgery for malignant pleural mesothelioma: a mini-review.
S. Halezeroğlu (2015)
Hyperthermic intraperitoneal chemotherapy is an independent risk factor for development of acute kidney injury
T. Dağel (2018)
EFECTOS SOBRE LAS CÉLULAS PLEURALES MALIGNAS DE LA HIPERTERMIA Y CISPLATINO: SÍNTESIS DE PROTEÍNAS PRO-INFLAMATORIAS Y APOPTOSIS CELULAR
Gregorio Guitián Crespo (2016)
Pleural carcinosis caused by extrathoracic malignancies
M. Migliore (2020)
Expertenempfehlung zur Anwendung der hyperthermen intrathorakalen Chemotherapie (HITOC) in Deutschland
Michael Ried (2020)
Intrapleural perfusion thermo-chemotherapy for pleural effusion caused by lung carcinoma under VATS.
R. Hu (2017)
Extended pleurectomy decortication: the current role.
R. Bilancia (2018)
Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis
Z. Zhao (2017)
Palliative Treatment of Malignant Pleural Effusion
C. Liu (2015)
Hyperthermic intrathoracic chemotherapy (HITHOC) in ovarian carcinoma - a propos of a case.
D. Stojiljković (2018)
How does the timing of chemotherapy affect outcome following radical surgery for malignant pleural mesothelioma?
A. Sharkey (2016)
Therapeutical effect of intrapleural perfusion with hyperthermic chemotherapy on malignant pleural effusion under video-assisted thoracoscopic surgery
X. Feng (2018)
Malignant pleural mesothelioma: between pragmatism and hope.
M. Migliore (2020)
Making precision surgical strategies a reality: are we ready for a paradigm shift in thoracic surgical oncology?
M. Migliore (2020)
Effect of hyperthermic intrathoracic chemotherapy (HITHOC) on the malignant pleural effusion
H. Zhou (2017)